Biocartis In Brief This Week: BGI, Gencove, Cepheid, Biocartis, Biognosys, Co-Diagnostics, More News items for the week of Jan. 10, 2022. Immunexpress Receives FDA 510(k) Clearance for Sepsis Assay The assay, which runs on the company's Idylla platform, distinguishes sepsis from noninfectious systemic inflammation. Biocartis H1 Revenues up 31 Percent The revenue growth was driven by sales of the company's Idylla molecular diagnostics system and related test cartridges. Biocartis Receives €1.4M Grant to Develop New Technology for Molecular Surveillance The grant will support development of next-generation technology for the firm's Idylla platform that would allow for the offline customization of cartridges. Biocartis, SkylineDx Partner to Develop Melanoma Nodal Metastasis Risk Test The Belgian molecular diagnostics firm also reported a 70 percent year-over-year increase in commercial cartridge volumes in the first quarter. Apr 20, 2021 Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer Mar 26, 2021 New Products Posted to GenomeWeb: Caris Life Sciences, Qlucore, Biocartis, More Feb 25, 2021 Biocartis Reports 15 Percent Rise in 2020 Revenues Nov 12, 2020 Biocartis Q3 Cartridge Volume Grows 61 Percent Nov 10, 2020 Biocartis Gets CE Mark for SARS-CoV-2 RT-PCR Test Nov 4, 2020 Biocartis to Invest in IVD Partnerships Following Termination of Genomic Health Deal Premium Nov 3, 2020 Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Oct 29, 2020 Biocartis, Exact Sciences Terminate Oncotype DX Agreement Sep 30, 2020 Biocartis Receives €1.2M Flemish Government Grant to Develop GeneFusion Assay on Idylla Platform Sep 3, 2020 Biocartis H1 Revenues Drop 2 Percent Sep 1, 2020 Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch Premium Jun 16, 2020 Immunexpress Nabs $599K BARDA Contract to Develop Sepsis Test for Coronavirus Patient Triage Apr 23, 2020 Biocartis Q1 Cartridge Volume Grows Sharply, Firm Suspends Placements Guidance Mar 26, 2020 Biocartis, Immunexpress Ink Co-Commercialization Agreement for Sepsis Test Mar 5, 2020 Biocartis Reports 35 Percent 2019 Revenue Rise, New Bristol-Myers Squibb CDx Project Jan 22, 2020 Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement Nov 14, 2019 Biocartis Increases Instrument Placements, Cartridge Volume in Q3; Inks Japan Distribution Deal Oct 25, 2019 New Products Posted to GenomeWeb: Biocartis, Synthego, Sophia Genetics Sep 5, 2019 Biocartis H1 2019 Revenues Rise 39 Percent Aug 2, 2019 Comparison of KRAS Liquid Biopsy Kits Confirms Differences at Low Mutant Allele Fraction Load More Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.